PubMed Health⌕ Search

Biomedical subjects

C Hengy

Publications and source records attributed to C Hengy.

At least 19 recordsLinked to original sources
PubMed1993

[Epidemiological features of retroviral infection by HTLV-1 in central Africa].

Subsaharian Africa is the most important reservoir of HTLV1 virus but its epidemiology is not well-known. The authors have studied from 1987 to 1990 the situation in 6 countries in Central Africa. The already described routes of transmission are present: through blood transfusions (but it's not such a common practice), heterosexual transmission (but it doesn't seem to be as important as in other continents), and mother to child transmission through breast feeding. Nevertheless, environmental factors--which have to investigated--could play a role for transmission, among them one could think to vectors and parasites.

Adolescent↗
PubMed1992

[Therapeutic attitudes and malaria in Sanaga Basin (Cameroon)].

In order to evaluate malaria problems such as they are perceived by Sanaga Basin populations in Cameroon, authors appealed to a cluster sample survey on a population sample obtained from a 2 degree population poll in four representative sites. Malaria so defined represents the outstanding endemia by which the most usual therapeutic recourse makes self-medication interfere particularly by amino-4-quinolines. It is convenient to verify the quality of treatment so administered to adapt possibly training objectives of the interested population. In the present context of the chemoresistance extension of plasmodial strains to usual antimalarials, setting up a surveillance system of efficiency is necessary.

Adolescent↗
PubMed1992

Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.

From simplified in vivo tests, authors set up a cartography of the sensitivity of Plasmodium falciparum to amino-4-quinolines in Cameroon; they also evaluated the clinical and parasitological efficacy of different therapeutic protocols which make use of amino-4-quinolines, quinine, mefloquine and halofantrine. All these drugs are administered orally. They recommend maintaining home medication with chloroquine at the dose of 25 mg/kg over 3 days, conserving quinine for use in the case of a possible failure. The use of most recent antimalarials can be proposed only as a last resort.

Administration, Oral↗
PubMed1991

Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance.

One hundred thirty nonimmune subjects living in Yaoundé, Cameroon, completed an 18-month prospective study on the efficacy and safety of weekly chloroquine and daily proguanil (chloroguanide) (Ch-P) in malaria prevention. A total of 9 of 78 Ch-P-treated subjects and 26 of 52 subjects who received no prophylaxis contracted Plasmodium falciparum infection during this period (P less than 0.00005). These two groups were comparable for demographic parameters and degree of exposure. Clinical manifestations were of similar severities in the two groups, but parasite counts were significantly higher in the subjects who received no prophylaxis (P less than 0.00005). Side effects of prophylaxis were frequent (31%), minor, and related to chloroquine, and they usually resolved within 4 to 6 weeks. Prolonged administration of Ch-P is safe and effectively prevents P. falciparum malaria in an endemic area with a high prevalence of chloroquine resistance.

Adult↗
PubMed1991

[Absence of epidemiologic interrelations between retroviral infection by HIV and human African trypanosomiasis (HAT)].

Authors are reporting results from 3 control-case surveys carried out in sleeping sickness foci in Cameroon, Central African Republic and Congo. HIV seroprevalence rates are comparable among sleeping sickness patients and trypanonegative control persons. These results lead towards the absence of inter-relationships between sleeping sickness and retroviral infection.

Adult↗
PubMed1991

[A survey of the prevalence of leprosy in 5 countries in central Africa].

The authors report the results of national surveys conducted in 5 Central Africa states: Cameroon, Congo, Gabon, Equatorial Guinea and RCA. The method used was cluster sampling among random populations. Only adults (greater than 15 years of age) took part in the study. The prevalence rates were between 6 and 14 per thousand. They are markedly higher than the official data.

Adolescent↗
PubMed1991

Reactivation of an old sleeping sickness focus in Mamfe (Cameroon): epidemiological, immunological and parasitological findings.

We report the reactivation of an old sleeping sickness focus in Mamfe (Cameroon). Screening of 9827 people using the Testryp CATT (card agglutination test for trypanosomiasis) gave a total of 137 positive cases (1.4%). The prevalence of CATT positivity was significantly linked to sex, age, place of residence and type of occupation of the people. 26 of these immunological suspects were later confirmed as sleeping sickness patients, giving a morbidity index of 0.26%. Only 44% of 16 sera from these confirmed patients were CATT positive on serum while only 31% of the sera had a positive Indirect Immunofluorescent Antibody Test (IFAT) reaction, supporting the hypothesis of the existence of a new T.b gambiense serodeme in this region. The reasons for the reactivation of this old sleeping sickness focus are discussed.

Adolescent↗
PubMed1990

[Epidemiology of infections caused by HIV-1, HIV-2 and HTLV-1 in the republic of Chad].

From March to July 1989 sero-epidemiological surveys have been carried out in four Chadian towns on representative samples of adults aged 15-44 years in the general population. For the first time, HIV1 virus circulation was shown off with seroprevalence rates varying from 0 to 1.1%. Rates are non-existent for HIV2 and they vary from 0 to 1.6% for HTLV1. These low seroprevalence rates make it difficult to identify special risk factors. There was confirmed a preponderance of heterosexual transmissions of these viruses.

Adolescent↗
PubMed1990

[Endemic leprosy in the People's Republic of Congo. An epidemiological and behavioral analysis].

The authors report the results of a national prevalence survey of leprosy made in 1989 in Popular Republic of Congo. Leprosy is essentially found in rural areas and frequently causes disabilities. The prevalence rate is 5.8 +/- 2.6% among people more than 15 years of age, and 10.5% of all forms are multibacillary. All patients are under DDS monotherapy. One overwhelming risk factor is leprosy cases in the family history; active case-finding and surveillance of contact cases are recommended. Generally, leprosy is poorly understood by the general population; an educational effort is necessary.

Adolescent↗
PubMed1990

[Uncomplicated attack of malaria in an area with high resistance to chloroquine. I. Evaluation of a short treatment with quinine].

The good results achieved in the treatment of malaria with a 7 and 5 days one of quinine (orally dose 8 mg/kg/8 h), incited the authors to try a 3 days long treatment at the same dose. They experimented this protocol on hospitalised children. All patients were free of parasites at day 7 with an average residual concentration quinine of 2.7 +/- 0.8 mg/l. Among the 7 patients with malaria at day 14, 4 didn't require another treatment and 2 presented new infestation. 50% of plasmodial isolated strains were chloroquine resistant and 40% amodiaquine resistant. The efficiency of this protocol could be in favour of its larger use.

Adolescent↗